Consistent engagement with current medical literature enables clinicians to apply the latest evidence-based treatment and integrate research into clinical practice. This approach enhances patient outcomes by facilitating more effective and individualized care.

Today, we’re showcasing some of the latest obstetrics and gynecology-related articles published recently across medical journals. The articles in today’s rundown focus on topics related to perimenopause and menopause. Article descriptions were edited for clarity and brevity.

Perimenopause Articles

Perimenopause as an Obesogenic Sensitive Period: Contributions to Elevated Cardiovascular Risk

  • American Journal of Preventive Cardiology, April 2026
  • Description: Perimenopause, encompassing the period of progressive menstrual irregularity preceding a woman’s final menstrual cycle and extending 12 months thereafter, is associated with an acceleration in atherosclerotic cardiovascular disease (CVD) risk, attributable in part to redistribution of body fat. [...] Concomitantly, women often experience a reduction in gluteofemoral subcutaneous adipose tissue. This pattern of fat redistribution is associated with a greater prevalence of CVD risk factors and a higher incidence of CVD events.
  • Summary
  • Full Text

Experiences of Weight and Body Shape changes During Perimenopause

  • Women & Health, February 2026
  • Description: Menopause indicates the end of the female reproductive lifespan. The hormonal shifts prior to this event result in a frequently symptomatic period known as perimenopause, which has been linked to unfavorable changes in body composition. This study explored women’s experiences of perimenopause, including perception of body shape and weight.
  • Summary
  • Full Text

Anxiety During Perimenopause: A Qualitative Study of Lived Experiences

  • Menopause, February 2026
  • Description: Perimenopause is associated with increased anxiety symptoms. However, data is lacking regarding the experiences of women with perimenopausal anxiety. We explored the experiences of women with new onset or worsening of anxiety symptoms during perimenopause to better understand lived experiences and contributing factors.
  • Summary
  • Full Text

Insulin Levels Early in Perimenopause Inform Vasomotor Symptom Incidence Across the Menopausal Transition

  • The Journal of Clinical Endocrinology and Metabolism, January 2026
  • Description: Metabolic health affects the menopausal transition. Metabolic characteristics like body mass index (BMI) affect vasomotor syndrome incidence, but the role of elevated insulin, an early marker of metabolic dysfunction, remains understudied.
  • Summary
  • Full Text
Menopause Articles

The Potential Role of Dietary (Poly)phenols in Cardiometabolic Risk During Menopause: A Narrative Review

  • Nutrients, April 2026
  • Description: This narrative review summarizes current evidence on the main cardiometabolic risk factors associated with menopause (i.e., obesity, dyslipidemia, high blood pressure, and insulin resistance) and examines the potential of dietary strategies focused on (poly)phenol intake to mitigate these alterations.
  • Summary
  • Full Text

Women’s Experiences with Diagnosis and Management of Vaginal Symptoms of Menopause: A Mixed-Methods Study

  • BMC Women’s Health, April 2026
  • Description: Vaginal symptoms associated with menopause affect around 50% of women. Although the multi-factorial impact of vaginal symptoms has been well explored, experience of management and treatment preferences are poorly understood.
  • Summary
  • Full Text

Association of Menopause and Hormone Replacement Therapy with Hearing Loss

  • The Annals of Otology, Rhinology, and Laryngology, April 2026
  • Description: Estrogen has been found to impact cochlear blood flow and auditory function, but epidemiological studies on menopause and hearing are inconsistent. This study investigates the associations of menopause, its age at onset, reproductive lifespan, and hormone replacement therapy (HRT) with hearing loss in adult women in the [United States].
  • Summary
  • Full Text

Estimated Impact of Fezolinetant Versus Placebo on Work Productivity and Indirect Costs Among Women Experiencing Vasomotor Symptoms Associated with Menopause

  • Menopause, March 2026
  • Description: This study evaluated the impact of fezolinetant versus placebo on work productivity and indirect costs among women with moderate to severe vasomotor symptoms (VMS) associated with menopause in seven countries.
  • Summary
  • Full Text

Look forward to more journal-focused topics in the coming weeks. 

Sign up for alerts and stay informed on the latest published articles and guidelines.